Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trial
View ORCID ProfileFrancesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, Carlo Salvarani, Roberto Parrella, Anna Maria Marata, Patrizia Popoli, Laurenzia Ferraris, Massimiliano M. Marrocco-Trischitta, Diego Ripamonti, Francesca Binda, Paolo Bonfanti, Nicola Squillace, Francesco Castelli, Maria Lorenza Muiesan, Miriam Lichtner, Carlo Calzetti, Nicola Duccio Salerno, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Cosimo Facciolongo, Fiorentino Fraganza, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Gerardo Botti, Claudia Cardone, Piera Gargiulo, Adriano Gravina, Clorinda Schettino, Laura Arenare, View ORCID ProfilePaolo Chiodini, View ORCID ProfileCiro Gallo on behalf of the TOCIVID-19 investigators (see Appendix for a complete list), Italy
doi: https://doi.org/10.1101/2020.06.01.20119149
Francesco Perrone
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDMaria Carmela Piccirillo
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDPaolo Antonio Ascierto
2Melanoma. Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDCarlo Salvarani
3Università degli Studi di Modena e Reggio Emilia and Azienda USL-IRCCS di Reggio Emilia
MDRoberto Parrella
4Cotugno Hospital, AORN Ospedali dei Colli, Napoli
MDAnna Maria Marata
5Emilia Romagna Health Directorate, Bologna
MDPatrizia Popoli
6Center for Drug Research and Evaluation, Istituto Superiore di Sanità, Roma
MDLaurenzia Ferraris
7Infectious Diseases Unit, Hospital Health Direction, IRCCS - Policlinico San Donato, Milano
MDMassimiliano M. Marrocco-Trischitta
7Infectious Diseases Unit, Hospital Health Direction, IRCCS - Policlinico San Donato, Milano
MDDiego Ripamonti
8Infectious Diseases Unit - ASST Papa Giovanni XXIII, Bergamo
MDFrancesca Binda
8Infectious Diseases Unit - ASST Papa Giovanni XXIII, Bergamo
MDPaolo Bonfanti
9Infectious Diseases Unit, ASST Monza and University Milano Bicocca
MDNicola Squillace
9Infectious Diseases Unit, ASST Monza and University Milano Bicocca
MDFrancesco Castelli
10University of Brescia and ASST Spedali Civili, Brescia
MDMaria Lorenza Muiesan
10University of Brescia and ASST Spedali Civili, Brescia
MDMiriam Lichtner
11Sapienza University of Rome, Santa Maria Goretti Hospital, Latina
MDCarlo Calzetti
12Infectious Diseases and Hepatology Unit AOU Parma
MDNicola Duccio Salerno
13UOC Malattie Infettive e Tropicali, AOUI, Verona
MDLuigi Atripaldi
4Cotugno Hospital, AORN Ospedali dei Colli, Napoli
MDMarco Cascella
14Anesthesia and Resuscitation Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDMassimo Costantini
15Azienda USL-IRCCS di Reggio Emilia
MDGiovanni Dolci
3Università degli Studi di Modena e Reggio Emilia and Azienda USL-IRCCS di Reggio Emilia
MDNicola Cosimo Facciolongo
15Azienda USL-IRCCS di Reggio Emilia
MDFiorentino Fraganza
4Cotugno Hospital, AORN Ospedali dei Colli, Napoli
MDMarco Massari
15Azienda USL-IRCCS di Reggio Emilia
MDVincenzo Montesarchio
4Cotugno Hospital, AORN Ospedali dei Colli, Napoli
MDCristina Mussini
16Università degli Studi di Modena e Reggio Emilia
MDEmanuele Alberto Negri
15Azienda USL-IRCCS di Reggio Emilia
MDGerardo Botti
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDClaudia Cardone
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDPiera Gargiulo
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDAdriano Gravina
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDClorinda Schettino
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MDLaura Arenare
1Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Napoli
MScPaolo Chiodini
17Department of Mental Health and Preventive Medicine, Università degli Studi della Campania Luigi Vanvitelli
MScCiro Gallo
17Department of Mental Health and Preventive Medicine, Università degli Studi della Campania Luigi Vanvitelli
MD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data will be made available in the near future.
Posted July 02, 2020.
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trial
Francesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, Carlo Salvarani, Roberto Parrella, Anna Maria Marata, Patrizia Popoli, Laurenzia Ferraris, Massimiliano M. Marrocco-Trischitta, Diego Ripamonti, Francesca Binda, Paolo Bonfanti, Nicola Squillace, Francesco Castelli, Maria Lorenza Muiesan, Miriam Lichtner, Carlo Calzetti, Nicola Duccio Salerno, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Cosimo Facciolongo, Fiorentino Fraganza, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Gerardo Botti, Claudia Cardone, Piera Gargiulo, Adriano Gravina, Clorinda Schettino, Laura Arenare, Paolo Chiodini, Ciro Gallo
medRxiv 2020.06.01.20119149; doi: https://doi.org/10.1101/2020.06.01.20119149
Tocilizumab for patients with COVID-19 pneumonia. The TOCIVID-19 prospective phase 2 trial
Francesco Perrone, Maria Carmela Piccirillo, Paolo Antonio Ascierto, Carlo Salvarani, Roberto Parrella, Anna Maria Marata, Patrizia Popoli, Laurenzia Ferraris, Massimiliano M. Marrocco-Trischitta, Diego Ripamonti, Francesca Binda, Paolo Bonfanti, Nicola Squillace, Francesco Castelli, Maria Lorenza Muiesan, Miriam Lichtner, Carlo Calzetti, Nicola Duccio Salerno, Luigi Atripaldi, Marco Cascella, Massimo Costantini, Giovanni Dolci, Nicola Cosimo Facciolongo, Fiorentino Fraganza, Marco Massari, Vincenzo Montesarchio, Cristina Mussini, Emanuele Alberto Negri, Gerardo Botti, Claudia Cardone, Piera Gargiulo, Adriano Gravina, Clorinda Schettino, Laura Arenare, Paolo Chiodini, Ciro Gallo
medRxiv 2020.06.01.20119149; doi: https://doi.org/10.1101/2020.06.01.20119149
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (669)
- Anesthesia (181)
- Cardiovascular Medicine (2650)
- Dermatology (223)
- Emergency Medicine (400)
- Epidemiology (12234)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4109)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2661)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3890)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6536)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (450)
- Toxicology (53)
- Transplantation (185)
- Urology (166)